{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,13]],"date-time":"2026-10-13T21:58:23Z","timestamp":1791928703758,"version":"4.3.4"},"reference-count":69,"publisher":"Association for Research in Vision and Ophthalmology (ARVO)","issue":"1","license":[{"start":{"date-parts":[[2019,1,18]],"date-time":"2019-01-18T00:00:00Z","timestamp":1547769600000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Invest. Ophthalmol. Vis. Sci."],"published-print":{"date-parts":[[2019,1,18]]},"DOI":"10.1167\/iovs.18-25624","type":"journal-article","created":{"date-parts":[[2019,1,18]],"date-time":"2019-01-18T11:30:47Z","timestamp":1547811047000},"page":"282","source":"Crossref","is-referenced-by-count":21,"title":["<i>VCAN<\/i>\n                    Canonical Splice Site Mutation is Associated With Vitreoretinal Degeneration and Disrupts an MMP Proteolytic Site"],"prefix":"10.1167","volume":"60","author":[{"given":"Peter H.","family":"Tang","sequence":"first","affiliation":[{"name":"Byers Eye Institute, Omics Laboratory, Department of Ophthalmology, Stanford University School of Medicine, Palo Alto, California, United States"},{"name":"Veterans Affairs Palo Alto Health Care System, Palo Alto, California, United States"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gabriel","family":"Velez","sequence":"additional","affiliation":[{"name":"Byers Eye Institute, Omics Laboratory, Department of Ophthalmology, Stanford University School of Medicine, Palo Alto, California, United States"},{"name":"Medical Scientist Training Program, University of Iowa, Iowa City, Iowa, United States"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stephen H.","family":"Tsang","sequence":"additional","affiliation":[{"name":"Bernard and Shirlee Brown Glaucoma Laboratory, Department of Pathology and Cell Biology, Department of Ophthalmology, College of Physicians and Surgeons, Columbia University, New York, New York, United States"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alexander G.","family":"Bassuk","sequence":"additional","affiliation":[{"name":"Department of Pediatrics, University of Iowa, Iowa City, Iowa, United States"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vinit B.","family":"Mahajan","sequence":"additional","affiliation":[{"name":"Byers Eye Institute, Omics Laboratory, Department of Ophthalmology, Stanford University School of Medicine, Palo Alto, California, United States"},{"name":"Veterans Affairs Palo Alto Health Care System, Palo Alto, California, United States"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"27","reference":[{"key":"i1552-5783-60-1-282-b01","doi-asserted-by":"crossref","unstructured":"Mukhopadhyay A, Nikopoulos K, Maugeri A, et al. Erosive vitreoretinopathy and wagner disease are caused by intronic mutations in CSPG2\/Versican that result in an imbalance of splice variants. Invest Ophthalmol Vis Sci. 2006; 47: 3565\u20133572.","DOI":"10.1167\/iovs.06-0141"},{"key":"i1552-5783-60-1-282-b02","doi-asserted-by":"crossref","unstructured":"Brown DM, Graemiger RA, Hergersberg M, et al. Genetic linkage of wagner disease and erosive vitreoretinopathy to chromosome 5q13-14. Arch Ophthalmol. 1995; 113: 671\u2013675.","DOI":"10.1001\/archopht.1995.01100050139045"},{"key":"i1552-5783-60-1-282-b03","unstructured":"Kloeckener-Gruissem B, Bartholdi D, Abdou MT, Zimmermann DR, Berger W. Identification of the genetic defect in the original Wagner syndrome family. Mol Vis. 2006; 12: 350\u2013355."},{"key":"i1552-5783-60-1-282-b04","doi-asserted-by":"crossref","unstructured":"Burin-des-Roziers C, Rothschild PR, Layet V, et al. Deletions overlapping VCAN exon 8 are new molecular defects for Wagner disease. Hum Mutat. 2017; 38: 43\u201347.","DOI":"10.1002\/humu.23124"},{"key":"i1552-5783-60-1-282-b05","doi-asserted-by":"crossref","unstructured":"Perveen R, Hart-Holden N, Dixon MJ, et al. Refined genetic and physical localization of the Wagner disease (WGN1) locus and the genes CRTL1 and CSPG2 to a 2- to 2.5-cM region of chromosome 5q14.3. Genomics. 1999; 57: 219\u2013226.","DOI":"10.1006\/geno.1999.5766"},{"key":"i1552-5783-60-1-282-b06","unstructured":"Rothschild PR, Brezin AP, Nedelec B, et al. A family with Wagner syndrome with uveitis and a new versican mutation. Mol Vis. 2013; 19: 2040\u20132049."},{"key":"i1552-5783-60-1-282-b07","doi-asserted-by":"crossref","unstructured":"Ronan SM, Tran-Viet KN, Burner EL, Metlapally R, Toth CA, Young TL. Mutational hot spot potential of a novel base pair mutation of the CSPG2 gene in a family with Wagner syndrome. Arch Ophthalmol. 2009; 127: 1511\u20131519.","DOI":"10.1001\/archophthalmol.2009.273"},{"key":"i1552-5783-60-1-282-b08","doi-asserted-by":"crossref","unstructured":"Mukhopadhyay A, Nikopoulos K, Maugeri A, et al. Erosive vitreoretinopathy and wagner disease are caused by intronic mutations in CSPG2\/Versican that result in an imbalance of splice variants. Invest Ophthalmol Vis Sci. 2006; 47: 3565\u20133572.","DOI":"10.1167\/iovs.06-0141"},{"key":"i1552-5783-60-1-282-b09","doi-asserted-by":"crossref","unstructured":"Miyamoto T, Inoue H, Sakamoto Y, et al. Identification of a novel splice site mutation of the CSPG2 gene in a Japanese family with Wagner syndrome. Invest Ophthalmol Vis Sci. 2005; 46: 2726\u20132735.","DOI":"10.1167\/iovs.05-0057"},{"key":"i1552-5783-60-1-282-b10","doi-asserted-by":"crossref","unstructured":"Kloeckener-Gruissem B, Neidhardt J, Magyar I, et al. Novel VCAN mutations and evidence for unbalanced alternative splicing in the pathogenesis of Wagner syndrome. Eur J Hum Genet. 2013; 21: 352\u2013356.","DOI":"10.1038\/ejhg.2012.137"},{"key":"i1552-5783-60-1-282-b11","unstructured":"Brezin AP, Nedelec B, Barjol A, Rothschild PR, Delpech M, Valleix S. A new VCAN\/versican splice acceptor site mutation in a French Wagner family associated with vascular and inflammatory ocular features. Mol Vis. 2011; 17: 1669\u20131678."},{"key":"i1552-5783-60-1-282-b12","doi-asserted-by":"crossref","unstructured":"Van Nouhuys CE. Chorioretinal dysplasia in young subjects with Wagner's hereditary vitreoretinal degeneration. Int Ophthalmol. 1981; 3: 67\u201377.","DOI":"10.1007\/BF00133417"},{"key":"i1552-5783-60-1-282-b13","doi-asserted-by":"crossref","unstructured":"Brown DM, Kimura AE, Weingeist TA, Stone EM. Erosive vitreoretinopathy. A new clinical entity. Ophthalmology. 1994; 101: 694\u2013704.","DOI":"10.1016\/S0161-6420(94)31276-0"},{"key":"i1552-5783-60-1-282-b14","unstructured":"Maumenee IH, Stoll HU, Mets MB. The Wagner syndrome versus hereditary arthroophthalmopathy. Trans Am Ophthalmol Soc. 1982; 80: 349\u2013365."},{"key":"i1552-5783-60-1-282-b15","doi-asserted-by":"crossref","unstructured":"Zhang Z, Miao L, Wang L. Inflammation amplification by Versican: the first mediator. Int J Mol Sci. 2012; 13: 6873\u20136882.","DOI":"10.3390\/ijms13066873"},{"key":"i1552-5783-60-1-282-b16","doi-asserted-by":"crossref","unstructured":"Passi A, Negrini D, Albertini R, Miserocchi G, De Luca G. The sensitivity of versican from rabbit lung to gelatinase A (MMP-2) and B (MMP-9) and its involvement in the development of hydraulic lung edema. FEBS Lett. 1999; 456: 93\u201396.","DOI":"10.1016\/S0014-5793(99)00929-1"},{"key":"i1552-5783-60-1-282-b17","doi-asserted-by":"crossref","unstructured":"Stanton H, Melrose J, Little CB, Fosang AJ. Proteoglycan degradation by the ADAMTS family of proteinases. Biochim Biophys Acta. 2011; 1812: 1616\u20131629.","DOI":"10.1016\/j.bbadis.2011.08.009"},{"key":"i1552-5783-60-1-282-b18","doi-asserted-by":"crossref","unstructured":"McCulloch DR, Nelson CM, Dixon LJ, et al. ADAMTS metalloproteases generate active versican fragments that regulate interdigital web regression. Dev Cell. 2009; 17: 687\u2013698.","DOI":"10.1016\/j.devcel.2009.09.008"},{"key":"i1552-5783-60-1-282-b19","doi-asserted-by":"crossref","unstructured":"Nandadasa S, Foulcer S, Apte SS. The multiple, complex roles of versican and its proteolytic turnover by ADAMTS proteases during embryogenesis. Matrix Biol. 2014; 35: 34\u201341.","DOI":"10.1016\/j.matbio.2014.01.005"},{"key":"i1552-5783-60-1-282-b20","doi-asserted-by":"crossref","unstructured":"Kloeckener-Gruissem B, Dours-Zimmermann MT, Skosyrski S, et al. A potential mouse model for the erosive vitreoretinopathy of Wagner disease. Matters. 2016; 2: e201605000004.","DOI":"10.19185\/matters.201605000004"},{"key":"i1552-5783-60-1-282-b21","doi-asserted-by":"crossref","unstructured":"Popp S, Maurel P, Andersen JS, Margolis RU. Developmental changes of aggrecan, versican and neurocan in the retina and optic nerve. Exp Eye Res. 2004; 79: 351\u2013356.","DOI":"10.1016\/j.exer.2004.05.016"},{"key":"i1552-5783-60-1-282-b22","doi-asserted-by":"crossref","unstructured":"Wolf LV, Yang Y, Wang J, et al. Identification of pax6-dependent gene regulatory networks in the mouse lens. PLoS One. 2009; 4: e4159.","DOI":"10.1371\/journal.pone.0004159"},{"key":"i1552-5783-60-1-282-b23","doi-asserted-by":"crossref","unstructured":"Benke K, Agg B, Szilveszter B, et al. The role of transforming growth factor-beta in Marfan syndrome. Cardiol J. 2013; 20: 227\u2013234.","DOI":"10.5603\/CJ.2013.0066"},{"key":"i1552-5783-60-1-282-b24","doi-asserted-by":"crossref","unstructured":"Miyamoto T, Inoue H, Sakamoto Y, et al. Identification of a novel splice site mutation of the CSPG2 gene in a Japenese family with Wagner syndrome. Invest Ophthalmol Vis Sci. 2005; 46: 2726\u20132735.","DOI":"10.1167\/iovs.05-0057"},{"key":"i1552-5783-60-1-282-b25","doi-asserted-by":"crossref","unstructured":"Ankala A, Jain N, Hubbard B, Alexander JJ, Shankar SP. Is exon 8 the most critical or the only dispensable exon of the VCAN gene? Insights into VCAN variants and clinical spectrum of Wagner syndrome. Am J Med Genet A. 2018; 176: 1778\u20131783.","DOI":"10.1002\/ajmg.a.38855"},{"key":"i1552-5783-60-1-282-b26","doi-asserted-by":"crossref","unstructured":"Skeie JM, Mahajan VB. Proteomic interactions in the mouse vitreous-retina complex. PLoS One. 2013; 8: e82140.","DOI":"10.1371\/journal.pone.0082140"},{"key":"i1552-5783-60-1-282-b27","doi-asserted-by":"crossref","unstructured":"Skeie JM, Roybal CN, Mahajan VB. Proteomic insight into the molecular function of the vitreous. PLoS One. 2015; 10: e0127567.","DOI":"10.1371\/journal.pone.0127567"},{"key":"i1552-5783-60-1-282-b28","doi-asserted-by":"crossref","unstructured":"Velez G, Tsang SH, Tsai YT, et al. Gene therapy restores Mfrp and corrects axial eye length. Sci Rep. 2017; 7: 16151.","DOI":"10.1038\/s41598-017-16275-8"},{"key":"i1552-5783-60-1-282-b29","doi-asserted-by":"crossref","unstructured":"Kumar S, Ratnikov BI, Kazanov MD, Smith JW, Cieplak. CleavPredict: a platform for reasoning about matrix metalloproteinases proteolytic events. PLoS One. 2015; 10: e0127877.","DOI":"10.1371\/journal.pone.0127877"},{"key":"i1552-5783-60-1-282-b30","doi-asserted-by":"crossref","unstructured":"Rawlings ND, Barrett AJ, Bateman A. MEROPS: the peptidase database. Nucleic Acids Res. 2010; 38: D227\u2013D233.","DOI":"10.1093\/nar\/gkp971"},{"key":"i1552-5783-60-1-282-b31","doi-asserted-by":"crossref","unstructured":"Trott O, Olson AJ. AutoDock Vina: improving the speed and accuracy of docking with a new scoring function, efficient optimization, and multithreading. J Comput Chem. 2010; 31: 455\u2013461.","DOI":"10.1002\/jcc.21334"},{"key":"i1552-5783-60-1-282-b32","doi-asserted-by":"crossref","unstructured":"Velez G, Machlab DA, Tang PH, et al. Proteomic analysis of the human retina reveals region-specific susceptibilities to metabolic- and oxidative stress-related diseases. PLoS One. 2018; 13: e0193250.","DOI":"10.1371\/journal.pone.0193250"},{"key":"i1552-5783-60-1-282-b33","doi-asserted-by":"crossref","unstructured":"Szklarczyk D, Franceschini A, Wyder S, et al. STRING v10: protein-protein interaction networks, integrated over the tree of life. Nucleic Acids Res. 2015; 43: D447\u2013D452.","DOI":"10.1093\/nar\/gku1003"},{"key":"i1552-5783-60-1-282-b34","doi-asserted-by":"crossref","unstructured":"Xia J, Gill EE, Hancock RE. NetworkAnalyst for statistical, visual and network-based meta-analysis of gene expression data. Nat Protoc. 2015; 10: 823\u2013844.","DOI":"10.1038\/nprot.2015.052"},{"key":"i1552-5783-60-1-282-b35","doi-asserted-by":"crossref","unstructured":"Shannon P, Markiel A, Ozier O, et al. Cytoscape: a software environment for integrated models of biomolecular interaction networks. Genome Res. 2003; 13: 2498\u20132504.","DOI":"10.1101\/gr.1239303"},{"key":"i1552-5783-60-1-282-b36","doi-asserted-by":"crossref","unstructured":"Koga T, Inatani M, Hirata A, et al. Expression of a chondroitin sulfate proteoglycan, versican (PG-M), during development of rat cornea. Curr Eye Res. 2005; 30: 455\u2013463.","DOI":"10.1080\/02713680590959376"},{"key":"i1552-5783-60-1-282-b37","doi-asserted-by":"crossref","unstructured":"Ueda J, Yue BY. Distribution of myocilin and extracellular matrix components in the corneoscleral meshwork of human eyes. Invest Ophthalmol Vis Sci. 2003; 44: 4772\u20134779.","DOI":"10.1167\/iovs.02-1002"},{"key":"i1552-5783-60-1-282-b38","doi-asserted-by":"crossref","unstructured":"Ohno-Jinno A, Isogai Z, Yoneda M, et al. Versican and fibrillin-1 form a major hyaluronan-binding complex in the ciliary body. Invest Ophthalmol Vis Sci. 2008; 49: 2870\u20132877.","DOI":"10.1167\/iovs.07-1488"},{"key":"i1552-5783-60-1-282-b39","doi-asserted-by":"crossref","unstructured":"Carnes MU, Allingham RR, Ashley-Koch A, Hauser MA. Transcriptome analysis of adult and fetal trabecular meshwork, cornea, and ciliary body tissues by RNA sequencing. Exp Eye Res 2018; 167: 91\u201399.","DOI":"10.1016\/j.exer.2016.11.021"},{"key":"i1552-5783-60-1-282-b40","doi-asserted-by":"crossref","unstructured":"Uhlen M, Fagerberg L, Hallstrom BM, et al. Proteomics. Tissue-based map of the human proteome. Science. 2015; 347: 1260419.","DOI":"10.1126\/science.1260419"},{"key":"i1552-5783-60-1-282-b41","doi-asserted-by":"crossref","unstructured":"Skeie JM, Mahajan VB. Proteomic landscape of the human choroid-retinal pigment epithelial complex. JAMA Ophthalmol. 2014; 132: 1271\u20131281.","DOI":"10.1001\/jamaophthalmol.2014.2065"},{"key":"i1552-5783-60-1-282-b42","doi-asserted-by":"crossref","unstructured":"Cabral T, Toral MA, Velez G, et al. Dissection of human retina and RPE-choroid for proteomic analysis. J Vis Exp. 2017; 129: e56203.","DOI":"10.3791\/56203"},{"key":"i1552-5783-60-1-282-b43","doi-asserted-by":"crossref","unstructured":"Wight TN. Versican: a versatile extracellular matrix proteoglycan in cell biology. Curr Opin Cell Biol. 2002; 14: 617\u2013623.","DOI":"10.1016\/S0955-0674(02)00375-7"},{"key":"i1552-5783-60-1-282-b44","doi-asserted-by":"crossref","unstructured":"Wu YJ, La-Pierre DP, Wu J, Yee AJ, Yang BB. The interaction of versican with its binding partners. Cell Res. 2005; 15: 483\u2013494.","DOI":"10.1038\/sj.cr.7290318"},{"key":"i1552-5783-60-1-282-b45","doi-asserted-by":"crossref","unstructured":"Theocharis DA, Skandalis SS, Noulas AV, Papageorgakopoulou N, Theocharis AD, Karamanos NK. Hyaluronan and chondroitin sulfate proteoglycans in the supramolecular organization of the mammalian vitreous body. Connect Tissue Res. 2008; 49: 124\u2013128.","DOI":"10.1080\/03008200802148496"},{"key":"i1552-5783-60-1-282-b46","doi-asserted-by":"crossref","unstructured":"Bishop PN. Structural macromolecules and supramolecular organisation of the vitreous gel. Prog Retin Eye Res. 2000; 19: 323\u2013344.","DOI":"10.1016\/S1350-9462(99)00016-6"},{"key":"i1552-5783-60-1-282-b47","doi-asserted-by":"crossref","unstructured":"Bassuk AG, Yeh S, Wu S, et al. Structural modeling of a novel CAPN5 mutation that causes uveitis and neovascular retinal detachment. PLoS One. 2015; 10: e0122352.","DOI":"10.1371\/journal.pone.0122352"},{"key":"i1552-5783-60-1-282-b48","doi-asserted-by":"crossref","unstructured":"Cox AJ, Darbro BW, Laxer RM, et al. Recessive coding and regulatory mutations in FBLIM1 underlie the pathogenesis of chronic recurrent multifocal osteomyelitis (CRMO). PLoS One. 2017; 12: e0169687.","DOI":"10.1371\/journal.pone.0169687"},{"key":"i1552-5783-60-1-282-b49","unstructured":"Moshfegh Y, Velez G, Li Y, Bassuk AG, Mahajan VB, Tsang SH. BESTROPHIN1 mutations cause defective chloride conductance in patient stem cell-derived RPE. Hum Mol Genet. 2016; 25: 2672\u20132680."},{"key":"i1552-5783-60-1-282-b50","doi-asserted-by":"crossref","unstructured":"Toral MA, Velez G, Boudreault K, et al. Structural modeling of a novel SLC38A8 mutation that causes foveal hypoplasia. Mol Genet Genomic Med. 2017; 5: 202\u2013209.","DOI":"10.1002\/mgg3.266"},{"key":"i1552-5783-60-1-282-b51","doi-asserted-by":"crossref","unstructured":"Velez G, Bassuk AG, Schaefer KA, et al. A novel de novo CAPN5 mutation in a patient with inflammatory vitreoretinopathy, hearing loss, and developmental delay. Cold Spring Harb Mol Case Stud. 2018; 4. a002519.","DOI":"10.1101\/mcs.a002519"},{"key":"i1552-5783-60-1-282-b52","doi-asserted-by":"crossref","unstructured":"Velez G, Tsang S, Tsai Y, et al. Gene therapy restores mfrp and corrects axial eye length. Sci Rep. 2017; 7: 16151.","DOI":"10.1038\/s41598-017-16275-8"},{"key":"i1552-5783-60-1-282-b53","doi-asserted-by":"crossref","unstructured":"Fields GB. Using fluorogenic peptide substrates to assay matrix metalloproteinases. Methods Mol Biol. 2010; 622: 393\u2013433.","DOI":"10.1007\/978-1-60327-299-5_24"},{"key":"i1552-5783-60-1-282-b54","unstructured":"Nagase H, Suzuki K, Morodomi T, Enghild JJ, Salvesen G. Activation mechanisms of the precursors of matrix metalloproteinases 1, 2 and 3. Matrix Suppl. 1992; 1: 237\u2013244."},{"key":"i1552-5783-60-1-282-b55","doi-asserted-by":"crossref","unstructured":"Ruoslahti E, Yamaguchi Y. Proteoglycans as modulators of growth factor activities. Cell. 1991; 64: 867\u2013869.","DOI":"10.1016\/0092-8674(91)90308-L"},{"key":"i1552-5783-60-1-282-b56","doi-asserted-by":"crossref","unstructured":"Doyle JJ, Gerber EE, Dietz HC. Matrix-dependent perturbation of TGFbeta signaling and disease. FEBS Lett. 2012; 586: 2003\u20132015.","DOI":"10.1016\/j.febslet.2012.05.027"},{"key":"i1552-5783-60-1-282-b57","doi-asserted-by":"crossref","unstructured":"Wu YJ, La Pierre DP, Wu J, Yee AJ, Yang BB. The interaction of versican with its binding partners. Cell Res. 2005; 15: 483\u2013494.","DOI":"10.1038\/sj.cr.7290318"},{"key":"i1552-5783-60-1-282-b58","doi-asserted-by":"crossref","unstructured":"Reinhard J, Renner M, Wiemann S, et al. Ischemic injury leads to extracellular matrix alterations in retina and optic nerve. Sci Rep. 2017; 7: 43470.","DOI":"10.1038\/srep43470"},{"key":"i1552-5783-60-1-282-b59","doi-asserted-by":"crossref","unstructured":"Kawashima H, Atarashi K, Hirose M, et al. Oversulfated chondroitin\/dermatan sulfates containing GlcAbeta1\/IdoAalpha1-3GalNAc(4,6-O-disulfate) interact with L- and P-selectin and chemokines. J Biol Chem. 2002; 277: 12921\u201312930.","DOI":"10.1074\/jbc.M200396200"},{"key":"i1552-5783-60-1-282-b60","doi-asserted-by":"crossref","unstructured":"Fu Y, Nagy JA, Brown LF, et al. Proteolytic cleavage of versican and involvement of ADAMTS-1 in VEGF-A\/VPF-induced pathological angiogenesis. J Histochem Cytochem. 2011; 59: 463\u2013473.","DOI":"10.1369\/0022155411401748"},{"key":"i1552-5783-60-1-282-b61","doi-asserted-by":"crossref","unstructured":"Pennock AT, Alam M, Bastrom T. Variation in tibial tubercle-trochlear groove measurement as a function of age, sex, size, and patellar instability. Am J Sports Med. 2014; 42: 389\u2013393.","DOI":"10.1177\/0363546513509058"},{"key":"i1552-5783-60-1-282-b62","doi-asserted-by":"crossref","unstructured":"Mohan N, Monickaraj F, Balasubramanyam M, Rema M, Mohan V. Imbalanced levels of angiogenic and angiostatic factors in vitreous, plasma and postmortem retinal tissue of patients with proliferative diabetic retinopathy. J Diabetes Complications. 2012; 26: 435\u2013441.","DOI":"10.1016\/j.jdiacomp.2012.05.005"},{"key":"i1552-5783-60-1-282-b63","doi-asserted-by":"crossref","unstructured":"Wight TN. Provisional matrix: a role for versican and hyaluronan. Matrix Biol. 2017; 60-61: 38\u201356.","DOI":"10.1016\/j.matbio.2016.12.001"},{"key":"i1552-5783-60-1-282-b64","doi-asserted-by":"crossref","unstructured":"Wight TN, Kang I, Merrilees MJ. Versican and the control of inflammation. Matrix Biol. 2014; 35: 152\u2013161.","DOI":"10.1016\/j.matbio.2014.01.015"},{"key":"i1552-5783-60-1-282-b65","doi-asserted-by":"crossref","unstructured":"Keire PA, Bressler SL, Lemire JM, et al. A role for versican in the development of leiomyosarcoma. J Biol Chem. 2014; 289: 34089\u201334103.","DOI":"10.1074\/jbc.M114.607168"},{"key":"i1552-5783-60-1-282-b66","unstructured":"Du WW, Yang W, Yee AJ. Roles of versican in cancer biology\u2014tumorigenesis, progression and metastasis. Histol Histopathol. 2013; 28: 701\u2013713."},{"key":"i1552-5783-60-1-282-b67","doi-asserted-by":"crossref","unstructured":"Ohno-Jinno A, Isoqai Z, Yoneda M, et al. Versican and fibrillin-1 form a major hyaluronan-binding complex in the ciliary body. Invest Ophthalmol Vis Sci. 2008; 49: 2870\u20132877.","DOI":"10.1167\/iovs.07-1488"},{"key":"i1552-5783-60-1-282-b68","doi-asserted-by":"crossref","unstructured":"Ramachandra CJ, Mehta A, Guo KW, Wong P, Tan JL, Shim W. Molecular pathogenesis of Marfan syndrome. Int J Cardiol. 2015; 187: 585\u2013591.","DOI":"10.1016\/j.ijcard.2015.03.423"},{"key":"i1552-5783-60-1-282-b69","doi-asserted-by":"crossref","unstructured":"Verstraeten A, Alaerts M, Van-Laer L, Loeys B. Marfan syndrome and related disorders: 25 years of gene discovery. Hum Mutat. 2016; 37: 524\u2013531.","DOI":"10.1002\/humu.22977"}],"container-title":["Investigative Opthalmology &amp; Visual Science"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/iovs.arvojournals.org\/article.aspx?articleid=2722740","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,10,13]],"date-time":"2026-10-13T21:31:06Z","timestamp":1791927066000},"score":1,"resource":{"primary":{"URL":"http:\/\/iovs.arvojournals.org\/article.aspx?doi=10.1167\/iovs.18-25624"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,1,18]]},"references-count":69,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2019,1,2]]}},"URL":"https:\/\/doi.org\/10.1167\/iovs.18-25624","relation":{},"ISSN":["1552-5783"],"issn-type":[{"value":"1552-5783","type":"print"}],"subject":[],"published":{"date-parts":[[2019,1,18]]}}}